rs267606604
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001042492.3(NF1):c.6007-5A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001042492.3 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- neurofibromatosis type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- neurofibromatosis-Noonan syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
- Moyamoya diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NF1 | NM_001042492.3 | c.6007-5A>G | splice_region_variant, intron_variant | Intron 40 of 57 | ENST00000358273.9 | NP_001035957.1 | ||
| NF1 | NM_000267.4 | c.5944-5A>G | splice_region_variant, intron_variant | Intron 39 of 56 | NP_000258.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:6
This sequence change falls in intron 39 of the NF1 gene. It does not directly change the encoded amino acid sequence of the NF1 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or altered protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with neurofibromatosis type 1 and/or NF1-related conditions (PMID: 7981692, 10712197, 11704931, 18546366, 24789688; internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 359). Studies have shown that this variant results in activation of a cryptic splice site, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 7981692, 11704931). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
- -
- -
- -
Juvenile myelomonocytic leukemia Pathogenic:1
- -
not provided Pathogenic:1
Non-canonical splice site variant demonstrated to result in aberrant splicing leading to a null allele in a gene for which loss-of-function is a known mechanism of disease (PMID: 11704931, 18546366, 24789688, 31370276, 32126153); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 7981692, 10712197, 32126153, 14569132, 11704931, 18546366, 24789688, 19221814, 31370276, 7542886, 37090834, 33919865) -
Neurofibromatosis, familial spinal Pathogenic:1
- -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The c.5944-5A>G intronic pathogenic mutation results from an A to G substitution 5 nucleotides upstream from coding exon 40 in the NF1 gene. This mutation has been reported in several individuals with a clinical or suspected diagnosis of neurofibromatosis type 1 (Ainsworth P et al. Hum Mol Genet, 1994 Jul;3:1179-81; Fahsold R et al. Am J Hum Genet, 2000 Mar;66:790-818; Kaufmann D et al. Am J Hum Genet, 2001 Dec;69:1395-400; Xu W et al. Int J Mol Med, 2014 Jul;34:53-60). In addition, this alteration results in the insertion of four nucleotides between NF1 exons 39 and 40, leading to creation of a premature stop codon (Ainsworth P et al. Hum Mol Genet, 1994 Jul;3:1179-81; Kaufmann D et al. Am J Hum Genet, 2001 Dec;69:1395-400; Xu W et al. Int J Mol Med, 2014 Jul;34:53-60; Ambry internal data). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at